Risk of temozolomide
coordination abnormal, viral infection, fever, nausea,, convulsions, rash, amnesia, insomnia, anorexia, asthenia, fatigue, diarrhea, leukopenia, alopecia, lymphopenia, neutropenia, constipation, dizziness, headache, hematologic laboratory abnormalities
ADVERSE REACTIONS, NEUTROPENIA, LEUKOPENIA, THROMBOCYTOPENIA, LYMPHOPENIA, ALLERGIC REACTIONS, ALOPECIA, ANOREXIA
The most common adverse reactions (≥10% incidence) are alopecia, fatigue, nausea, vomiting, headache, constipation, anorexia, convulsions, rash, hemiparesis, diarrhea, asthenia, fever, dizziness, coordination abnormal, viral infection, amnesia, and insomnia. The most common Grade 3 to 4 hematologic laboratory abnormalities (≥10% incidence) that have developed during treatment with temozolomide are: lymphopenia, thrombocytopenia, neutropenia, and leukopenia. Allergic reactions have also been reported. See package insert for full details.